ホーム>>D-myo-Inositol-1,3,4,5,6-pentaphosphate (sodium salt)

D-myo-Inositol-1,3,4,5,6-pentaphosphate (sodium salt) (Synonyms: Ins(1,3,4,5,6)P5, 1,3,4,5,6IP5)

カタログ番号GC43515

リン脂質イノシトール3キナーゼ(PI3K)/ Aktシグナル伝達経路は、細胞の成長と増殖に重要な役割を果たすため、抗がん剤の魅力的な標的となっています。

Products are for research use only. Not for human use. We do not sell to patients.

D-myo-Inositol-1,3,4,5,6-pentaphosphate (sodium salt) 化学構造

サイズ 価格 在庫数 個数
100μg
$83.00
在庫あり
500μg
$378.00
在庫あり
1mg
$672.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

The phosphatidylinositol 3-kinase (PI3K)/Akt signal transduction pathway plays critical roles in cell growth and proliferation making it an attractive target for anticancer agents. Inositol-1,3,4,5,6-pentaphosphate (Ins(1,3,4,5,6)P5) is one of the many inositol phosphate isomers that act as small, soluble second messengers in the transmission of cellular signals. It can be interconverted with Ins(3,4,5,6)P4 by a 1-kinase/1-phosphatase cycle, as well as with Ins(1,4,5,6)P4 in a 3-kinase/3-phosphatase cycle. Ins(1,3,4,5,6)P5 inhibits the phosphorylation and kinase activity of Akt/PKB, inducing apoptosis in ovarian, lung, and breast cancer cells. It exhibits antiangiogenic activity in vitro, blocking capillary tube formation of HUVEC, as well as antitumor effects against cancer xenografts in nude mice. Ins(1,3,4,5,6)P5 binds to the PH domain of Grp1 with a Kd value of 590 nM.

レビュー

Review for D-myo-Inositol-1,3,4,5,6-pentaphosphate (sodium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 29 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for D-myo-Inositol-1,3,4,5,6-pentaphosphate (sodium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.